NANEXA.ST
Price:
$3.055
Market Cap:
$484.76M
Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-06-17
Stock Exchange
STO
Ticker
NANEXA.ST
According to Nanexa AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 2.08. This represents a change of -14.82% compared to the average of 2.44 of the last 4 quarters.
The mean historical Current Ratio of Nanexa AB (publ) over the last ten years is 4.17. The current 2.08 Current Ratio has changed 4.89% with respect to the historical average. Over the past ten years (40 quarters), NANEXA.ST's Current Ratio was at its highest in in the September 2021 quarter at 15.79. The Current Ratio was at its lowest in in the September 2023 quarter at 0.78.
Average
4.17
Median
2.42
Minimum
1.04
Maximum
9.84
Discovering the peaks and valleys of Nanexa AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 60.55%
Maximum Annual Current Ratio = 9.84
Minimum Annual Increase = -77.10%
Minimum Annual Current Ratio = 1.04
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 1.04 | -58.70% |
| 2023 | 2.53 | 9.36% |
| 2022 | 2.31 | -76.50% |
| 2021 | 9.84 | 348.38% |
| 2020 | 2.19 | 5.47% |
| 2019 | 2.08 | 1.74% |
| 2018 | 2.04 | -77.10% |
| 2017 | 8.93 | 10.73% |
| 2016 | 8.06 | 196.79% |
| 2015 | 2.72 | 60.55% |
The current Current Ratio of Nanexa AB (publ) (NANEXA.ST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.96
5-year avg
3.58
10-year avg
4.17
Nanexa AB (publ)’s Current Ratio is less than AlzeCure Pharma AB (publ) (4.75), greater than Xintela AB (publ) (0.23), less than Acarix AB (publ) (9.47), less than Elicera Therapeutics AB (publ) (5.35), greater than Enorama Pharma AB (publ) (0.71), less than Moberg Pharma AB (publ) (16.14), less than Promimic AB (publ) (3.57), greater than Boule Diagnostics AB (publ) (1.10), greater than Mentice AB (publ) (0.97), greater than Physitrack PLC (0.63),
| Company | Current Ratio | Market cap |
|---|---|---|
| 4.75 | $252.81M | |
| 0.23 | $178.65M | |
| 9.47 | $348.35M | |
| 5.35 | $285.39M | |
| 0.71 | $150.67M | |
| 16.14 | $422.77M | |
| 3.57 | $317.39M | |
| 1.10 | $202.71M | |
| 0.97 | $371.41M | |
| 0.63 | $221.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanexa AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nanexa AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Nanexa AB (publ)'s Current Ratio?
How is the Current Ratio calculated for Nanexa AB (publ) (NANEXA.ST)?
What is the highest Current Ratio for Nanexa AB (publ) (NANEXA.ST)?
What is the 3-year average Current Ratio for Nanexa AB (publ) (NANEXA.ST)?
What is the 5-year average Current Ratio for Nanexa AB (publ) (NANEXA.ST)?
How does the current Current Ratio for Nanexa AB (publ) (NANEXA.ST) compare to its historical average?